vs
费森尤斯医疗（FMS）与金佰利（KMB）财务数据对比。点击上方公司名可切换其他公司
费森尤斯医疗的季度营收约是金佰利的1.3倍（$5.5B vs $4.2B），金佰利净利率更高（16.2% vs 7.9%，领先8.3%），金佰利同比增速更快（2.7% vs -0.3%）
费森尤斯医疗是德国知名医疗保健企业，核心业务为肾脏透析服务，在全球运营4171家门诊透析中心，服务约34.54万名患者。公司主要为终末期肾病患者提供治疗服务，该类患者需终身每周接受3次透析治疗以维持生命。
金佰利是源自美国的跨国消费品及个人护理集团，主打纸质类消费品，同时生产卫生用纸制品、外科及医疗器具。旗下拥有舒洁面巾纸、高洁丝女性护理产品、好奇纸尿裤及婴儿湿巾、Scott卫生纸等知名品牌，产品销往全球多个国家和地区。
FMS vs KMB — 直观对比
营收规模更大
FMS
是对方的1.3倍
$4.2B
营收增速更快
KMB
高出3.0%
-0.3%
净利率更高
KMB
高出8.3%
7.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $5.5B | $4.2B |
| 净利润 | $434.2M | $675.0M |
| 毛利率 | 27.4% | 36.8% |
| 营业利润率 | 11.7% | 18.1% |
| 净利率 | 7.9% | 16.2% |
| 营收同比 | -0.3% | 2.7% |
| 净利润同比 | 240.4% | 17.8% |
| 每股收益（稀释后） | — | $2.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FMSKMB
| Q1 26 | — | $4.2B | ||
| Q4 25 | $5.5B | $3.3B | ||
| Q3 25 | — | $4.2B | ||
| Q2 25 | — | $4.2B | ||
| Q1 25 | — | $4.8B | ||
| Q4 24 | $5.5B | $4.9B | ||
| Q3 24 | — | $5.0B | ||
| Q2 24 | — | $5.0B |
净利润FMSKMB
| Q1 26 | — | $675.0M | ||
| Q4 25 | $434.2M | $499.0M | ||
| Q3 25 | — | $446.0M | ||
| Q2 25 | — | $509.0M | ||
| Q1 25 | — | $567.0M | ||
| Q4 24 | $127.6M | $447.0M | ||
| Q3 24 | — | $907.0M | ||
| Q2 24 | — | $544.0M |
毛利率FMSKMB
| Q1 26 | — | 36.8% | ||
| Q4 25 | 27.4% | 37.7% | ||
| Q3 25 | — | 36.0% | ||
| Q2 25 | — | 35.0% | ||
| Q1 25 | — | 35.8% | ||
| Q4 24 | 25.0% | 34.0% | ||
| Q3 24 | — | 36.0% | ||
| Q2 24 | — | 36.0% |
营业利润率FMSKMB
| Q1 26 | — | 18.1% | ||
| Q4 25 | 11.7% | 11.2% | ||
| Q3 25 | — | 15.0% | ||
| Q2 25 | — | 14.2% | ||
| Q1 25 | — | 15.9% | ||
| Q4 24 | 5.1% | 11.1% | ||
| Q3 24 | — | 23.3% | ||
| Q2 24 | — | 13.0% |
净利率FMSKMB
| Q1 26 | — | 16.2% | ||
| Q4 25 | 7.9% | 15.1% | ||
| Q3 25 | — | 10.7% | ||
| Q2 25 | — | 12.2% | ||
| Q1 25 | — | 11.7% | ||
| Q4 24 | 2.3% | 9.1% | ||
| Q3 24 | — | 18.3% | ||
| Q2 24 | — | 10.8% |
每股收益（稀释后）FMSKMB
| Q1 26 | — | $2.00 | ||
| Q4 25 | — | $1.50 | ||
| Q3 25 | — | $1.34 | ||
| Q2 25 | — | $1.53 | ||
| Q1 25 | — | $1.70 | ||
| Q4 24 | — | $1.34 | ||
| Q3 24 | — | $2.69 | ||
| Q2 24 | — | $1.61 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.7B | $542.0K |
| 总债务越低越好 | — | $6.5M |
| 股东权益账面价值 | $15.4B | $1.9M |
| 总资产 | $33.5B | $17.2M |
| 负债/权益比越低杠杆越低 | — | 3.38× |
8季度趋势，按日历期对齐
现金及短期投资FMSKMB
| Q1 26 | — | $542.0K | ||
| Q4 25 | $1.7B | $688.0M | ||
| Q3 25 | — | $617.0M | ||
| Q2 25 | — | $634.0M | ||
| Q1 25 | — | $563.0M | ||
| Q4 24 | $1.3B | $1.0B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.2B |
总债务FMSKMB
| Q1 26 | — | $6.5M | ||
| Q4 25 | — | $6.5B | ||
| Q3 25 | — | $6.5B | ||
| Q2 25 | — | $6.5B | ||
| Q1 25 | — | $6.5B | ||
| Q4 24 | — | $6.9B | ||
| Q3 24 | — | $6.9B | ||
| Q2 24 | — | $7.2B |
股东权益FMSKMB
| Q1 26 | — | $1.9M | ||
| Q4 25 | $15.4B | $1.5B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | $17.0B | $840.0M | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.1B |
总资产FMSKMB
| Q1 26 | — | $17.2M | ||
| Q4 25 | $33.5B | $17.1B | ||
| Q3 25 | — | $16.9B | ||
| Q2 25 | — | $16.8B | ||
| Q1 25 | — | $16.3B | ||
| Q4 24 | $36.3B | $16.5B | ||
| Q3 24 | — | $17.2B | ||
| Q2 24 | — | $17.3B |
负债/权益比FMSKMB
| Q1 26 | — | 3.38× | ||
| Q4 25 | — | 4.31× | ||
| Q3 25 | — | 4.86× | ||
| Q2 25 | — | 5.09× | ||
| Q1 25 | — | 5.89× | ||
| Q4 24 | — | 8.18× | ||
| Q3 24 | — | 5.36× | ||
| Q2 24 | — | 6.30× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.9B | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 6.67× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FMSKMB
| Q1 26 | — | — | ||
| Q4 25 | $2.9B | $972.0M | ||
| Q3 25 | — | $708.0M | ||
| Q2 25 | — | $770.0M | ||
| Q1 25 | — | $327.0M | ||
| Q4 24 | $2.6B | $817.0M | ||
| Q3 24 | — | $958.0M | ||
| Q2 24 | — | $1.0B |
自由现金流FMSKMB
| Q1 26 | — | — | ||
| Q4 25 | — | $575.0M | ||
| Q3 25 | — | $368.0M | ||
| Q2 25 | — | $573.0M | ||
| Q1 25 | — | $123.0M | ||
| Q4 24 | — | $608.0M | ||
| Q3 24 | — | $798.0M | ||
| Q2 24 | — | $863.0M |
自由现金流率FMSKMB
| Q1 26 | — | — | ||
| Q4 25 | — | 17.5% | ||
| Q3 25 | — | 8.9% | ||
| Q2 25 | — | 13.8% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | — | 12.3% | ||
| Q3 24 | — | 16.1% | ||
| Q2 24 | — | 17.2% |
资本支出强度FMSKMB
| Q1 26 | — | — | ||
| Q4 25 | — | 12.1% | ||
| Q3 25 | — | 8.2% | ||
| Q2 25 | — | 4.7% | ||
| Q1 25 | — | 4.2% | ||
| Q4 24 | — | 4.2% | ||
| Q3 24 | — | 3.2% | ||
| Q2 24 | — | 3.1% |
现金转化率FMSKMB
| Q1 26 | — | — | ||
| Q4 25 | 6.67× | 1.95× | ||
| Q3 25 | — | 1.59× | ||
| Q2 25 | — | 1.51× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | 20.20× | 1.83× | ||
| Q3 24 | — | 1.06× | ||
| Q2 24 | — | 1.88× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FMS
暂无分部数据
KMB
| NA | $2.7B | 64% |
| IPC | $1.5B | 36% |
